V
Voyager Therapeutics
Gene therapies for neurological diseases crossing blood-brain barrier.
At a glance
- Status
- Listed
- Listing
- IPO 2015
News
Open roles
Voyager Therapeutics in the Cambridge ecosystem
The Voyager Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later10 investors entered at this stage
Wellington Management
Casdin Capital- BCBrookside Capital
- PSPFM Health Sciences
- USUniversity of Massachusetts Medical School
Fidelity Investments- UCUniversity of California
- SFSan Francisco
Foresite Capital- SUStanford University
Source: Dealroom Talent Intelligence.
Alumni founders
Former Voyager Therapeutics employees who went on to found companies, sorted by Dealroom signal score.
STSeaport TherapeuticsEst. 2024
Steven PaulUnited States
VTVima TherapeuticsEst. 2023
Bernard RavinaUnited States
LTLogicBio TherapeuticsEst. 2015
Mark MdUnited States
GBGeneration BioEst. 2016
Robert KotinUnited StatesPatents
80 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Voyager Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


